Скачать или смотреть Heart Failure and Fluid Overload - alfapump® DSR

Heart failure and fluid overload


Fluid overload in heart failure is a major clinical problem and is the leading cause of hospitalisations for patients with heart failure. There are approximately one million hospitalisations for heart failure annually in the U.S. and 90% are due to symptoms of fluid overload. The treatment options are severely limited in those patients for whom diuretic therapy is no longer effective. This limitation is evident from the 24% hospital re-admission rate at 30 days from discharge. The estimated cost of heart failure-related hospitalisations in the U.S. alone is $13 billion per year.


At Sequana Medical, we are developing the alfapump® DSR as potential chronic therapy for patients with fluid overload due to heart failure.